ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suga, T
Right arrow Articles by Kitamura, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suga, T
Right arrow Articles by Kitamura, S
Eur Respir J 1994; 7: 2249-2251
Copyright © ERS Journals Ltd 1994

Case Studies

Bronchioloalveolar carcinoma with bronchorrhoea treated with erythromycin

T Suga, Y Sugiyama, T Fujii, and S Kitamura

Recent reports have shown that erythromycin inhibits bronchial hypersecretion, and, accordingly, erythromycin was administered to a patient with bronchioloalveolar carcinoma with bronchorrhoea. After administration of erythromycin, marked reduction in the volume of sputum was observed, and the patient's quality of life was improved. It is concluded that erythromycin may reduce hypersecretion in bronchioloalveolar carcinoma.


This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
F. Barlesi, C. Doddoli, P. Thomas, J.-P. Kleisbauer, R. Giudicelli, and P. Fuentes
Bilateral bronchioloalveolar lung carcinoma: is there a place for palliative pneumonectomy?
Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1113 - 1116.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the European Respiratory Society.